Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Efficacy and Safety of Monotherapy With Mycophenolate Mofetil in Liver Transplantation Patients With Nephrotoxicity — Cristina Miranda Cruz (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Efficacy and Safety of Monotherapy With Mycophenolate Mofetil in Liver Transplantation Patients With Nephrotoxicity
Shared by
Jesus Simal Gandara
Universidade de Vigo
Efficacy and Safety of Monotherapy With Mycophenolate Mofetil in Liver Transplantation Patients With Nephrotoxicity
Article
2016
en
Authors
+4 more
CC
Cristina Miranda Cruz
SP
Sheila Pereira
Jesus Simal Gandara
Universidade de Vigo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation
Dario Cattaneo
,
Norberto Perico
,
Flavio Gaspari
,
Eliana Gotti
,
Giuseppe Remuzzi
Letter
2009
Mycophenolate Mofetil Versus Azathioprine in Organ Transplantation
Paolo Cravedi
,
Annalisa Perna
,
Piero Ruggenenti
,
Giuseppe Remuzzi
Letter
2006
Is Mycophenolate Mofetil Better Than Azathioprine in Organ Transplantation?
Piero Ruggenenti
,
Giuseppe Remuzzi
Letter
2008
Pharmacokinetic/Pharmacodynamic Drug Interaction Between Rosiglitazone and Mycophenolate Mofetil in Kidney Transplantation
Dario Cattaneo
,
Alessandra Bitto
,
Sara Baldelli
,
Monica Cortinovis
,
Eliana Gotti
,
Norberto Perico
,
Giuseppe Remuzzi
Article
2007
Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation
Giuseppe Remuzzi
,
Paolo Cravedi
,
Marco Costantini
,
Mariadomenica Lesti
,
María Ganeva
,
Giulia Gherardi
,
Bogdan Ene‐Iordache
,
Eliana Gotti
,
Donato Donati
,
Maurizio Salvadori
,
Silvio Sandrini
,
Giuseppe Segoloni
,
Stefano Federico
,
Paolo Rigotti
,
Vito Sparacino
,
Piero Ruggenenti
Discussion(0)
No comments yet. Be the first to comment.